SR One portfolio

SR One (Venture capital) is known to hold 41 companies, 18 of them startups. 11 of them are hiring now, with 78 open roles. Its companies closed 4 venture rounds in 12 months, raising $332.4M. Most of them work in Drug Discovery, Prescription Drugs, Cell & Gene Therapy.

Source: Alion Venture capital Oct 7, 2026
Investments
41
18 of them startups
Hiring now
11
78 open roles
Rounds in 12 months
4
$332.4M raised
Exits
7

Companies SR One has invested in

Fore Biotherapeutics Series D $67.4M · 3 mo ago portfolio pageOct 3
Veradermics Dermatology · United States Convertible Note $30M · 5 mo ago portfolio pageOct 3
Addition Therapeutics Cell & Gene Therapy · United States Venture round $100M · 9 mo ago 5 roles portfolio pageOct 3
Avenzo Therapeutics Series B $60M · 12 mo ago 4 roles portfolio pageOct 3
Charm Therapeutics United Kingdom Series B $80M · 13 mo ago portfolio pageOct 3
Windward Bio Drug Discovery Series A $200M · 20 mo ago portfolio pageOct 3
Akamis Bio Series A $60M · 21 mo ago portfolio pageOct 3
Nomic Bioinformatics Series B $42M · 2 yr ago portfolio pageOct 3
Alumis Prescription Drugs · United States Venture round $40M · 2 yr ago 1 role portfolio pageOct 3
Pulmocide Infectious Disease Therapeutics Venture round $52M · 3 yr ago portfolio pageOct 3
One moment, please... United States Venture round $62.5M · 4 yr ago portfolio pageOct 3
Biotheryx United States Venture round $92.1M · 5 yr ago portfolio pageOct 3
Mineralystx Prescription Drugs 25 roles portfolio pageOct 3
crisprtx Cell & Gene Therapy 14 roles portfolio pageOct 3
Zenas BioPharma Biologics & Biosimilars · United States 9 roles portfolio pageOct 3
Avalynpharma Prescription Drugs · United States 4 roles portfolio pageOct 3
Nkarta, Inc. Cell & Gene Therapy 4 roles portfolio pageOct 3
Bicycle Therapeutics Prescription Drugs · United Kingdom 2 roles portfolio pageOct 3
1.1 Design Therapeutics, Inc. Genomics & Genetic Testing portfolio pageOct 3
AirNexis Respiratory & Sleep Devices portfolio pageOct 3
Ancora Biotech Cardiometabolic Therapeutics portfolio pageOct 3
Odyssey Immunology & Inflammation Therapeutics portfolio pageOct 3

Focus

Markets
Drug Discovery10%
Prescription Drugs10%
Cell & Gene Therapy7%
Immunology & Inflammation Therapeutics7%
Rare Disease Therapeutics5%
Cardiometabolic Therapeutics5%
Biologics & Biosimilars5%
Respiratory & Sleep Devices2%
Where its companies are
United States17%
United Kingdom5%
Stage of its companies
Venture, series not stated50%
Series B25%
Series A17%
Series C and later8%

Questions about SR One

How many companies has SR One invested in?

SR One is known to hold 41 companies: 18 startups, and 7 exits so far, read from its own portfolio page and the funding rounds that name it.

Is SR One investing now?

SR One has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does SR One invest in?

The markets of the companies SR One holds: Drug Discovery (10%), Prescription Drugs (10%), Cell & Gene Therapy (7%), Immunology & Inflammation Therapeutics (7%), Rare Disease Therapeutics (5%).

Which SR One portfolio companies are hiring?

11 companies SR One holds are hiring now, with 78 open roles listed on this page.

Who does SR One invest alongside?

The investors that hold the most companies together with SR One: OrbiMed, HBM Healthcare Investments, RA Capital Management, Wellington Management, Longitude Capital.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3

SR One portfolio: 41 known companies. Alion, Oct 7, 2026. https://alion.io/company/sr-one/portfolio

Licence: CC BY-SA 4.0JSON